Home > Research areas > Immunobiology of inflammation
  • Programme Area 1

Immunobiology of inflammation

  • Autoinflammation
  • Innate Immunity
  • System immunology

Understanding the links between innate immunity, chronic inflammatory disease and healthy ageing

The Eicke Latz laboratory is dedicated to uncovering the fundamental mechanisms of innate immune activation that play a crucial role in autoinflammatory, rheumatologic and chronic inflammatory diseases. Utilizing a blend of systems immunology, experimental biology, and human translational science, the lab seeks to understand how the innate immune system either maintains balance or contributes to the development of inflammatory diseases. The insights gained are crucial for a variety of auto-inflammatory, autoimmune, and chronic inflammatory conditions. To validate the significance of their discoveries, the laboratory utilizes preclinical models and reverse translational methods, which encompass the use of biomaterials sourced from patients and the implementation of observational clinical trials. The lab’s research has led to the identification of new therapeutic targets, resulting in the creation of several biotech companies aimed at converting these basic research discoveries into innovative treatments and preventive strategies.

Team

Group leader
Prof. Dr. med. Eicke Latz

Science coordination
Pia Langhoff, PhD

Berlin Lab
Scientists
James Gearing, PhD
Cassandra Harapas, PhD
Ana Kitanovic, PhD
Igor Kitanovic, PhD
Daniel Simpson, PhD

PhD Students
Melanie Nuesch-Germano

Technical staff
Olga  Pogasiy

Bonn Lab
Scientists

Matthew Mangan, PhD
Kateryna Shkarina, PhD
Dennis de Graaf, PhD

PHD Students
Anil Akbal
Marta Lovotti
Matilde Vasconcelos
Christabel Mennicken
Alesja Dernst
Aurelia Merbecks
Theresa Wagner

Technical staff
Gudrun Engels
Romina Kaiser
Fraser Duthie
Rainer Stahl

Main cooperation partners

Gerhard Krönke, Thomas Dörner, Tilmann Kallinich, Andrey Kruglov, Max Löhning, Vikram Sunkara

FMP, DIfE, LIT

Uni Bonn (several groups), Gene Center Munich (Hornung)

Bayer Pharma

Kensuke Miyake (Tokyo), Kate Fitzgerald (UMass)

Novartis, AlamarBio, Absae